Answers are grounded in this paper and cite their sources.
The article represents the role of high-dose chemotherapy following autologous hematopoietic stem cell transplantation for Hodgkin lymphoma and summarizes the results of 10-years’ experience of high-dose chemotherapy following autologous hematopoietic stem transplantation cell for Hodgkin lymphoma in N.I. Pirogov National Medical and Surgical Center. 5-year overall survival was 63 %, 5-year progressivefree survival – 84 % that corresponds with international data. Complete response before high-dose chemotherapy following autologous hematopoietic stem cell was the main independent prognostic factor of transplantation efficacy. transplantation.
No takes yet. Share an insight, caveat, or question.
Mochkin et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: